drugset / Trial / NCT06340724

Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication

NCT06340724

RandomizedParallel-groupOpen-labelTreatment

Summary

Vonoprazan and high-dose amoxicillin dual therapy was used as a control group to evaluate the clinical efficiency and safety of Banxiaxiexin decoction combined with vonoprazan and high-dose amoxicillin dual therapy in the treatment of helicobacter pylori infection complicated with functional dyspepsia,through a randomized controlled trail.

Timeline

Start
2024-02-15
Primary completion
2024-11-30
Completion
2025-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Banxiaxiexin decoction Unknown 100 ml Oral
Background Amoxicillin Other / unclassified 1 g Oral
Background Vonoprazan Other / unclassified 20 mg Oral